Point72 Hong Kong Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 193 filers reported holding HERON THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Point72 Hong Kong Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$108,000
+125.0%
25,518
+205.4%
0.00%
+100.0%
Q1 2022$48,000
-34.2%
8,355
+23.1%
0.00%0.0%
Q3 2021$73,000
+135.5%
6,787
+241.1%
0.00%
+100.0%
Q2 2021$31,000
+1450.0%
1,990
+1024.3%
0.00%0.0%
Q1 2020$2,000
+100.0%
177
+276.6%
0.00%
Q3 2018$1,000
-98.7%
47
-97.7%
0.00%
-100.0%
Q2 2018$79,0002,0240.03%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders